0
0
LUND, SWEDEN — In a breakthrough for regenerative medicine, researchers at Lund University have successfully transformed the brain’s support cells into specialized neurons that act as the organ’s “braking system.” The study, published this week in Science Advances, offers a potential roadmap for treating neurological conditions like schizophrenia and epilepsy by replacing lost or damaged cells directly within the brain.
The research team, led by Dr. Daniella Rylander Ottosson, has developed a method to skip the traditional, time-consuming stem-cell stage. Instead, they “reprogram” glial cells—non-neuronal cells that provide structure and protection—directly into parvalbumin-positive (PV) interneurons. These specific neurons are responsible for maintaining the brain’s delicate electrical equilibrium, essentially preventing the neural “noise” that leads to cognitive dysfunction or seizures.
The Brain’s Internal Metronome
To understand the significance of this discovery, one must look at how the brain manages its own energy. If the brain were an orchestra, parvalbumin cells would be the conductor, ensuring that every instrument plays at the right volume and tempo.
“Parvalbumin cells act as the brain’s rapid-braking system,” explains Dr. Rylander Ottosson, a researcher in regenerative neurophysiology. “They control nerve cell signaling, reduce overactivity, and ensure that the brain is working to a rhythm. Researchers sometimes describe them as the cells that ‘make the brain sound right.'”
When these “conductors” are damaged or missing, the result is neural chaos. In epilepsy, the lack of inhibitory braking leads to the electrical storms known as seizures. In schizophrenia, the loss of these cells is linked to the cognitive “static” and hallucinations experienced by patients.
Skipping the ‘Detour’: A Shortcut in Cellular Engineering
Traditionally, creating specific types of brain cells in a lab involves taking a cell back to its most primitive state—a stem cell—and then coaxing it to become a neuron. This process is not only slow but particularly difficult for parvalbumin cells, which naturally develop very late in human fetal growth.
The Lund University team bypassed this hurdle using a technique called direct reprogramming. By activating a specific cocktail of genes, they “forced” human glial cells to abandon their identity as support cells and transform into PV neurons.
“By activating the correct genes, we force the glial cells to transform into parvalbumin cells, without the detour via stem cells,” says Rylander Ottosson. “In our study, we have for the first time succeeded in reprogramming human glial cells into parvalbumin neurons that resemble those that naturally exist in the brain.”
The team also identified a specific lineage pathway—specifically for chandelier cells, a highly specialized type of PV neuron—that allows for more precise targeting than ever before.
Implications for Public Health
The potential applications for this research are twofold, impacting both immediate diagnostic capabilities and long-term therapeutic goals.
1. Modeling Disease in a Dish
In the short term, this method allows scientists to take glial cells from a patient with schizophrenia or epilepsy and turn them into PV neurons in a laboratory setting. This creates a “personalized” model of the patient’s brain, allowing researchers to study exactly why those cells might be failing and to test new medications on them without any risk to the patient.
2. Direct Brain Repair
In the long term, the hope is to move from the lab to the clinic. If researchers can safely trigger this reprogramming inside a living human brain, they could theoretically “regrow” the brain’s braking system in areas where it has been depleted. This would represent a shift from managing symptoms with medication to actually repairing the underlying neural architecture.
Statistical Context and Expert Perspective
The need for such innovation is urgent. According to the World Health Organization (WHO), epilepsy affects approximately 50 million people worldwide, making it one of the most common neurological diseases globally. Furthermore, schizophrenia affects roughly 24 million people, or 1 in 300 people worldwide.
Independent experts caution that while the results are promising, the transition to human therapy remains years away.
“This is a sophisticated piece of bio-engineering,” says Dr. Marcus Thorne, a neurobiologist not involved in the study. “The ability to generate PV neurons without a stem-cell intermediary solves a massive production bottleneck. However, we must ensure these ‘reprogrammed’ cells can integrate into existing human neural circuits safely without causing unintended electrical disruptions.”
Challenges and Considerations
While the study marks a milestone, it is not without its limitations. Direct reprogramming in a lab dish is one thing; doing so in the complex, crowded environment of a human brain is another.
-
Precision: Researchers must ensure that only the intended cells are reprogrammed to avoid depleting the brain’s essential support structure (glia).
-
Longevity: It remains to be seen if these lab-created neurons can survive for decades, as natural neurons do.
-
Safety: Like all genetic therapies, there is a rigorous testing period required to ensure the gene-activation process does not lead to unwanted cell growth or tumors.
Moving Forward
The Lund University researchers are now focused on fine-tuning the method using the new genes they have identified. Their goal is to increase the efficiency of the transformation and begin testing the integration of these cells in more complex biological systems.
For the millions living with neurological disorders that currently have no cure, this “shortcut” in cellular identity offers a new glimmer of hope for a future where the brain’s balance can be restored from within.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
https://medicalxpress.com/news/2026-01-cells-brain-cool.html
